NCT04608734View on ClinicalTrials.gov

Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

June 13, 2016

Study Completion Date

June 25, 2016

Conditions
Dental Anxiety
Interventions
DRUG

Buccal midazolam

The drug was sprayed in the buccal vestibule across the area between the primary first and second molars in all four quadrants to maximize the absorption through wide area of the buccal mucosa.

DRUG

Intranasal midazolam

Half of the dose was sprayed in the right nostril and the other half in the left nostril to double the absorptive surface area by short and quick puffs.

Trial Locations (1)

21512

Faculty of Dentistry, Alexandria University, Alexandria

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Nourhan M.Aly

OTHER

NCT04608734 - Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients | Biotech Hunter | Biotech Hunter